Evidence map›Paper›PMID 42592634›Full record

ArticleMedical cannabis and cannabinoids

Marijuana Use for Symptom Control in Inflammatory Bowel Disease: Patients' Perceptions and Patterns of Use.

Arvin Daneshmand, Karen Yung, Hanzhi Gao, Chelsea Salmon, Nofel Iftikhar, Saroja Devi Rampertab, Angela Kim Pham, Ludmila De Faria, Ellen Mary Zimmermann, Naueen A Chaudhry

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medical cannabis and cannabinoids. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Arvin DaneshmandDepartment of Gastroenterology and Hepatology, University of Florida, Gainesville, FL, USA.
Karen YungDepartment of Gastroenterology and Hepatology, University of Florida, Gainesville, FL, USA.
Hanzhi GaoDepartment of Biostatistics, University of Florida, Gainesville, FL, USA.
Chelsea SalmonDepartment of Gastroenterology and Hepatology, University of Florida, Gainesville, FL, USA.
Nofel IftikharDepartment of Gastroenterology and Hepatology, University of Florida, Gainesville, FL, USA.
Saroja Devi RampertabDepartment of Gastroenterology and Hepatology, University of Florida, Gainesville, FL, USA.
Angela Kim PhamDepartment of Gastroenterology and Hepatology, University of Florida, Gainesville, FL, USA.
Ludmila De FariaDepartment of Psychiatry, University of Florida, Gainesville, FL, USA.
Ellen Mary ZimmermannDepartment of Gastroenterology and Hepatology, University of Florida, Gainesville, FL, USA.
Naueen A ChaudhryDepartment of Gastroenterology and Hepatology, University of Florida, Gainesville, FL, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Many patients with inflammatory bowel disease (IBD) use marijuana for disease-related symptoms. Data regarding reasons for usage, impact, and perceptions on its effects is lacking. Our study aimed to understand patterns of marijuana use, underlying symptom response, and beliefs about marijuana in patients with IBD. Methods: An anonymous REDCap survey comprised of 39 questions on demographics, disease features, patterns of marijuana use, symptoms, quality of life, and true/false statements about marijuana was administered to 108 participants recruited from University of Florida (UF) IBD clinic. Results: Participants were 47.2% male and 51.9% female. While a significant percentage of subjects reported co-morbid depression/anxiety (61.1%), the percentages for PTSD and ADHD are both 19.4%. Patient characteristics are compared among three reasons of marijuana use (Recreational, Medical and Combination). There was a notable shift in reasons for use with both age ( Conclusions: Marijuana can be helpful for symptom control, reducing reliance on opioid pharmaceuticals, and may improve quality of life in patients with IBD. Participants demonstrated good insight regarding the role of marijuana in the management of their disease.

Indexed as

AnxietyCrohn’s diseaseInflammatory bowel diseaseMarijuanaOpioid use disorderQuality of lifeUlcerative colitis

Identifiers

PMID42592634
PMCPMC13466465

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.